- Home
- DRCT vs GDTC Comparison
DRCT vs GDTC Comparison
Compare DRCT & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- GDTC
- Stock Information
- Founded
- DRCT 2018
- GDTC 2018
- Country
- DRCT United States
- GDTC Singapore
- Employees
- DRCT N/A
- GDTC N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- GDTC Health Care
- Exchange
- DRCT Nasdaq
- GDTC Nasdaq
- Market Cap
- DRCT 9.2M
- GDTC 21.5M
- IPO Year
- DRCT 2022
- GDTC 2023
- Fundamental
- Price
- DRCT $0.41
- GDTC $2.03
- Analyst Decision
- DRCT Strong Buy
- GDTC Buy
- Analyst Count
- DRCT 1
- GDTC 1
- Target Price
- DRCT $6.00
- GDTC $5.00
- AVG Volume (30 Days)
- DRCT 220.4K
- GDTC 13.2K
- Earning Date
- DRCT 11-11-2025
- GDTC 01-01-0001
- Dividend Yield
- DRCT N/A
- GDTC N/A
- EPS Growth
- DRCT N/A
- GDTC N/A
- EPS
- DRCT N/A
- GDTC N/A
- Revenue
- DRCT $36,459,000.00
- GDTC $368,838.00
- Revenue This Year
- DRCT $16.81
- GDTC $5.37
- Revenue Next Year
- DRCT $62.96
- GDTC N/A
- P/E Ratio
- DRCT N/A
- GDTC N/A
- Revenue Growth
- DRCT N/A
- GDTC N/A
- 52 Week Low
- DRCT $0.38
- GDTC $1.20
- 52 Week High
- DRCT $6.59
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- DRCT 40.25
- GDTC 51.85
- Support Level
- DRCT $0.40
- GDTC N/A
- Resistance Level
- DRCT $0.49
- GDTC $2.27
- Average True Range (ATR)
- DRCT 0.03
- GDTC 0.10
- MACD
- DRCT 0.00
- GDTC -0.06
- Stochastic Oscillator
- DRCT 21.35
- GDTC 87.67
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.